Helping you make better health choices

In shops now or delivered to your home from only £3.50 an issue!

Subscribe!

Vioxx payouts

MagazineMarch 2006 (Vol. 16 Issue 12)Vioxx payouts

There, drug giant Merck is facing 6400 separate lawsuits from patients, or their surviving relatives, who claim that its COX-2 anti-inflammatory Vioxx (rofecoxib) has caused heart attack or stroke

There, drug giant Merck is facing 6400 separate lawsuits from patients, or their surviving relatives, who claim that its COX-2 anti-inflammatory Vioxx (rofecoxib) has caused heart attack or stroke.

Merck lost the first case in August when a Texas jury found in favour of a patient's family and awarded compensation of $253 million.

But then, in November, Merck enjoyed a small victory when a New Jersey jury decided that Vioxx had not caused a heart attack in a 60-year-old postal worker.

So now, there are a mere 6398 cases to go, and Merck is committed to fighting every one of them. If it goes badly, analysts estimate the actions could cost Merck around $35 billion in compensation - and that's just for the cases that have been filed thus far.

These are indeed worrying times for drug companies. If word gets out that their products are killing patients, where might it all end? So please, don't tell a soul (Lancet, 2005; 366: 1763-4).


Selling drugs

Trusting the process

You may also be interested in...

Sign up for free today

Sign up now to get your FREE 17-point Plan to Great Health

Free membership gives you access to our latest news reports, use of our community area, forums, blogs, readers' health tips and our twice-weekly
e-news letter.

WDDTY Recommends

Latest Tweet

About

Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, cancer, depression and many other chronic conditions.

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

Most Popular Health Website of the Year 2014

© 2010 - 2016 WDDTY Publishing Ltd.
All Rights Reserved